ANI PHARMACEUTICALS, INC Litigation Settlement, Amount Awarded to Other Party
ANI PHARMACEUTICALS, INC (ANIP) had Litigation Settlement, Amount Awarded to Other Party of $8.40 million as of 2021-08-03, per its 10-Q filed 2021-11-01.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LitigationSettlementAmountAwardedToOtherParty · last filed 2021-11-01
- 2021-08-03: Litigation Settlement, Amount Awarded to Other Party $8.40M.
| Period end | Litigation Settlement, Amount Awarded to Other Party |
|---|---|
| 2021-08-03 | $8.40M 10-Q · filed 2021-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |